Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Prilosec OTC Soothes P&G First Quarter Forecast As Early Shipments Rollout

This article was originally published in The Tan Sheet

Executive Summary

Stronger than expected initial orders for Prilosec OTC are responsible in part for Procter & Gamble's increase in its first quarter earnings guidance for fiscal year 2004
Advertisement

Related Content

GSK, Galpharm Pioneer UK Nonprescription Omeprazole Market
GSK, Galpharm Pioneer UK Nonprescription Omeprazole Market
Zantac 75 Ad Comparison to Prilosec OTC Needs Revision, NAD Concludes
Prilosec OTC Demand Taxing P&G Supply Chain Efficiency
Prilosec OTC Brandname Defended By P&G In Response To Petition
Prilosec OTC Claims Found False; P&G Appeals Federal Court Ruling
J&J/Merck Challenge Prilosec OTC Claims; Insurer Incentives Support Launch
Prilosec OTC Name Will Create Consumer Confusion With Rx Drugs – Petition
Prilosec OTC Heats Up Heartburn Sector; Competitors Set Sights On Launch
Prilosec OTC Heats Up Heartburn Sector; Competitors Set Sights On Launch

Topics

Advertisement
UsernamePublicRestriction

Register

PS095907

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel